David A. Constant

710 total citations
17 papers, 463 citations indexed

About

David A. Constant is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, David A. Constant has authored 17 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in David A. Constant's work include Viral gastroenteritis research and epidemiology (5 papers), Respiratory viral infections research (3 papers) and Immune Response and Inflammation (3 papers). David A. Constant is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), Respiratory viral infections research (3 papers) and Immune Response and Inflammation (3 papers). David A. Constant collaborates with scholars based in United States, United Kingdom and Austria. David A. Constant's co-authors include Timothy J. Nice, Karla Kirkegaard, Isabella Rauch, Louis J. Thibodeaux, Dipak Roy, Donald Dean Adrian, Kyoung S. Ro, Kalliat T. Valsaraj, Claude M. Nagamine and Roberto Mateo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Science Advances.

In The Last Decade

David A. Constant

15 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Constant United States 11 127 125 80 56 56 17 463
Sian Stafford United Kingdom 8 155 1.2× 128 1.0× 96 1.2× 26 0.5× 159 2.8× 11 600
Ellen Lanckacker Belgium 14 136 1.1× 137 1.1× 79 1.0× 84 1.5× 148 2.6× 18 519
Budhadev Baral India 14 159 1.3× 107 0.9× 69 0.9× 27 0.5× 42 0.8× 28 459
Toshiki G. Nakashige United States 12 406 3.2× 133 1.1× 107 1.3× 35 0.6× 78 1.4× 15 837
Tze Yan Lee Malaysia 9 93 0.7× 112 0.9× 72 0.9× 23 0.4× 76 1.4× 23 383
Benjamin A. Gilston United States 8 289 2.3× 83 0.7× 61 0.8× 37 0.7× 45 0.8× 10 582
Liang Hua China 14 231 1.8× 123 1.0× 54 0.7× 56 1.0× 55 1.0× 20 744
Michael Stockelman United States 13 245 1.9× 66 0.5× 22 0.3× 31 0.6× 69 1.2× 17 560
Ganne Venkata Sudhakar Rao India 6 107 0.8× 63 0.5× 36 0.5× 65 1.2× 45 0.8× 26 334
Lìyǐng Zhū China 17 173 1.4× 99 0.8× 49 0.6× 20 0.4× 106 1.9× 58 726

Countries citing papers authored by David A. Constant

Since Specialization
Citations

This map shows the geographic impact of David A. Constant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Constant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Constant more than expected).

Fields of papers citing papers by David A. Constant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Constant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Constant. The network helps show where David A. Constant may publish in the future.

Co-authorship network of co-authors of David A. Constant

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Constant. A scholar is included among the top collaborators of David A. Constant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Constant. David A. Constant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Constant, David A., et al.. (2025). Homeostatic antiviral protection of the neonatal gut epithelium by interferon lambda. Cell Reports. 44(2). 115243–115243. 2 indexed citations
2.
Constant, David A., et al.. (2024). Homeostatic pockets of interferon lambda-stimulated gene production in the intestine are associated with localized exposure to bacterial microbiota. Gut Microbes. 17(1). 2447830–2447830. 1 indexed citations
3.
Rauch, Isabella, et al.. (2024). Interferon regulatory factor 6 (IRF6) determines intestinal epithelial cell development and immunity. Mucosal Immunology. 17(4). 633–650. 5 indexed citations
4.
Naseer, Nawar, Renate Bauer, David A. Constant, et al.. (2022). Salmonella enterica Serovar Typhimurium Induces NAIP/NLRC4- and NLRP3/ASC-Independent, Caspase-4-Dependent Inflammasome Activation in Human Intestinal Epithelial Cells. Infection and Immunity. 90(7). e0066321–e0066321. 40 indexed citations
5.
Constant, David A., et al.. (2022). Transcriptional and Cytotoxic Responses of Human Intestinal Organoids to IFN Types I, II, and III. ImmunoHorizons. 6(7). 416–429. 10 indexed citations
6.
Peterson, Stefan T., Elizabeth A. Kennedy, Michael J. Wheadon, et al.. (2022). Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium. eLife. 11. 35 indexed citations
7.
Constant, David A., Timothy J. Nice, & Isabella Rauch. (2021). Innate immune sensing by epithelial barriers. Current Opinion in Immunology. 73. 1–8. 21 indexed citations
8.
Horve, Patrick F., Leslie Dietz, Mark Fretz, et al.. (2021). Identification of SARS‐CoV‐2 RNA in healthcare heating, ventilation, and air conditioning units. Indoor Air. 31(6). 1826–1832. 33 indexed citations
9.
Constant, David A., et al.. (2021). Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases. Frontiers in Immunology. 12. 767505–767505. 20 indexed citations
10.
Horve, Patrick F., Alison Edelman, Leslie Dietz, et al.. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Environmental Contamination and Childbirth. Obstetrics and Gynecology. 136(4). 827–829. 12 indexed citations
11.
Jones, Samuel T., Valeria Cagno, M. Janecek, et al.. (2020). Modified cyclodextrins as broad-spectrum antivirals. Science Advances. 6(5). eaax9318–eaax9318. 139 indexed citations
12.
Constant, David A., Bowen Liu, Roberto Mateo, et al.. (2020). A Targeted Computational Screen of the SWEETLEAD Database Reveals FDA-Approved Compounds with Anti-Dengue Viral Activity. mBio. 11(6). 5 indexed citations
13.
Jones, Samuel T., Valeria Cagno, M. Janecek, et al.. (2020). Modified cyclodextrins as broad-spectrum antivirals. Zenodo (CERN European Organization for Nuclear Research).
14.
Constant, David A., et al.. (2020). Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity. Journal of Virology. 94(21). 27 indexed citations
15.
Constant, David A., Roberto Mateo, Claude M. Nagamine, & Karla Kirkegaard. (2018). Targeting intramolecular proteinase NS2B/3 cleavages for trans -dominant inhibition of dengue virus. Proceedings of the National Academy of Sciences. 115(40). 10136–10141. 35 indexed citations
16.
Ro, Kyoung S., Donald Dean Adrian, David A. Constant, et al.. (1996). Solubility of 2,4,6-Trinitrotoluene (TNT) in Water. Journal of Chemical & Engineering Data. 41(4). 758–761. 77 indexed citations
17.
Constant, David A.. (1993). The productivity paradox; Why hasn't information technology fulfilled its promise?. ACM SIGCHI Bulletin. 25(4). 42–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026